GLP/GIP Agonists are an injectable medication that combines dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists to promote weight loss and improve metabolic health. At Gramercy Park Integrative, we utilize GLP/GIP Agonists as part of a comprehensive, physician-guided program tailored to your unique health profile. This treatment helps reduce appetite, slow gastric emptying, and enhance insulin sensitivity—resulting in significant weight reduction and better control of blood sugar levels. Our team ensures ongoing monitoring and adjustments to maximize results and minimize side effects. GLP/GIP Agonists offer a powerful, clinically validated solution for individuals struggling with obesity or weight-related health conditions, especially when combined with lifestyle changes and expert support.
Obesity and weight-related health conditions can significantly impact overall wellness and quality of life. Often linked to insulin resistance, cardiovascular disease, and hormonal imbalances, excess weight presents a complex challenge. GLP/GIP Agonists target the biological mechanisms that contribute to weight gain and difficulty losing weight. By mimicking natural hormones involved in hunger regulation and glucose control, it provides a medically advanced solution to address root causes. This treatment is ideal for patients who have struggled with conventional diets or medications without lasting success. At Gramercy Park Integrative, we take a whole-person approach to weight management, supporting both physical transformation and long-term health improvements through individualized care.
GLP/GIP Agonists are a dual-action injectable medication that activates both GIP and GLP-1 receptors, hormones involved in glucose regulation and appetite control. It works by slowing down digestion, reducing food intake, improving insulin sensitivity, and decreasing hunger. This unique combination leads to effective and sustained weight loss, especially when used alongside a medically guided lifestyle plan.
GLP/GIP Agonists are ideal for adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who also have weight-related health conditions like type 2 diabetes or high blood pressure. It is especially suited for individuals who have not had success with diet, exercise, or other medications alone. A consultation is required to determine eligibility.
Some patients may experience mild side effects such as nausea, vomiting, constipation, or diarrhea as their body adjusts to the medication. These symptoms are usually temporary and can be minimized with dosage adjustments and dietary guidance. Rare but serious side effects include pancreatitis or gallbladder issues, which are monitored closely by our medical team throughout treatment.
Many patients begin to see weight loss within the first few weeks, with more significant results typically observed after several months of consistent treatment. The timeline can vary depending on individual factors such as starting weight, metabolism, and adherence to the treatment plan. Regular follow-ups ensure that the program remains effective and tailored to your goals.